Gefitinib Tablets Ip 250 Mg - Medicine Grade, Anti-cancer Function, Suitable For Adults, 1 Year Shelf Life

Geftisym 250 Tablet is used in the treatment of non-small cell lung cancer. It is used in patients in which it has spread to other parts of the body, who have abnormal epidermal growth factor receptor (EGFR) genes, and who have not had previous treatment for cancer.

Geftisym 250 Tablet should be taken in a dose as recommended by the doctor. You should continue to take it as long as your doctor advises for it. The duration of treatment varies according to your need and response to treatment. Your doctor may advice for regular monitoring of liver function while your taking this medicine.

Common side effects include diarrhea, dry skin, loss of appetite, and nausea. Drink plenty of fluids to reduce the risk of side effects. Inform your doctor if any of the side effects bother you or get worse. In case you develop ulceration in mouth, changes in your vision, or breathing difficulties than it is better to inform the doctor.

Women who are undergoing treatment should use effective contraception method. It is important to avoid pregnancy during the treatment and for a month after completing the course of medicine. Let your doctor also know about all the other medications you are taking.

Uses of Geftisym 250 Tablet

Pancreatic cancer
Small cell lung cancer
Liver cancer
Kidney cancer
Thyroid cancer
Blood cancer (Chronic myeloid leukaemia)
Gastrointestinal stromal tumour
Cancer of colon and rectum
Non-small cell lung cancer
Soft tissue sarcoma
Chronic idiopathic myelofibrosis
Breast cancer